Condensed Consolidated Statements of Stockholders' Equity - USD ($) $ in Thousands |
Total |
Common Stock |
Additional Paid-In Capital |
Accumulated Other Comprehensive Income (Loss) |
Accumulated Deficit |
Treasury Stock |
Beginning balance (in shares) at Dec. 31, 2023 |
|
72,161,489,000
|
|
|
|
|
Beginning balance at Dec. 31, 2023 |
$ 811,019
|
$ 72
|
$ 2,436,523
|
$ (441)
|
$ (822,649)
|
$ (802,486)
|
Treasury stock, beginning balance (in shares) at Dec. 31, 2023 |
|
|
|
|
|
(16,216,411,000)
|
Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
Unrealized gain (loss) on available-for-sale securities |
(646)
|
|
|
(646)
|
|
|
Common stock issued under stock incentive plan and ESPP (in shares) |
|
806,433,000
|
|
|
|
|
Common stock issued under stock incentive plan and ESPP |
5,864
|
$ 1
|
5,863
|
|
|
|
Stock-based compensation expense |
9,234
|
|
9,234
|
|
|
|
Net loss |
(81,549)
|
|
|
|
(81,549)
|
|
Ending balance (in shares) at Mar. 31, 2024 |
|
72,967,922,000
|
|
|
|
|
Ending balance at Mar. 31, 2024 |
743,922
|
$ 73
|
2,451,620
|
(1,087)
|
(904,198)
|
$ (802,486)
|
Treasury stock, ending balance (in shares) at Mar. 31, 2024 |
|
|
|
|
|
(16,216,411,000)
|
Beginning balance (in shares) at Dec. 31, 2023 |
|
72,161,489,000
|
|
|
|
|
Beginning balance at Dec. 31, 2023 |
811,019
|
$ 72
|
2,436,523
|
(441)
|
(822,649)
|
$ (802,486)
|
Treasury stock, beginning balance (in shares) at Dec. 31, 2023 |
|
|
|
|
|
(16,216,411,000)
|
Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
Net loss |
(177,667)
|
|
|
|
|
|
Ending balance (in shares) at Jun. 30, 2024 |
|
73,091,490,000
|
|
|
|
|
Ending balance at Jun. 30, 2024 |
660,510
|
$ 73
|
2,464,284
|
(1,045)
|
(1,000,316)
|
$ (802,486)
|
Treasury stock, ending balance (in shares) at Jun. 30, 2024 |
|
|
|
|
|
(16,216,411,000)
|
Beginning balance (in shares) at Mar. 31, 2024 |
|
72,967,922,000
|
|
|
|
|
Beginning balance at Mar. 31, 2024 |
743,922
|
$ 73
|
2,451,620
|
(1,087)
|
(904,198)
|
$ (802,486)
|
Treasury stock, beginning balance (in shares) at Mar. 31, 2024 |
|
|
|
|
|
(16,216,411,000)
|
Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
Unrealized gain (loss) on available-for-sale securities |
42
|
|
|
42
|
|
|
Common stock issued under stock incentive plan and ESPP (in shares) |
|
123,568,000
|
|
|
|
|
Common stock issued under stock incentive plan and ESPP |
1,099
|
|
1,099
|
|
|
|
Stock-based compensation expense |
11,565
|
|
11,565
|
|
|
|
Net loss |
(96,118)
|
|
|
|
(96,118)
|
|
Ending balance (in shares) at Jun. 30, 2024 |
|
73,091,490,000
|
|
|
|
|
Ending balance at Jun. 30, 2024 |
$ 660,510
|
$ 73
|
2,464,284
|
(1,045)
|
(1,000,316)
|
$ (802,486)
|
Treasury stock, ending balance (in shares) at Jun. 30, 2024 |
|
|
|
|
|
(16,216,411,000)
|
Beginning balance (in shares) at Dec. 31, 2024 |
57,156,285
|
73,372,696,000
|
|
|
|
|
Beginning balance at Dec. 31, 2024 |
$ 1,540,956
|
$ 73
|
2,493,811
|
(1,518)
|
(148,924)
|
$ (802,486)
|
Treasury stock, beginning balance (in shares) at Dec. 31, 2024 |
(16,216,411)
|
|
|
|
|
(16,216,411)
|
Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
Unrealized gain (loss) on available-for-sale securities |
$ 1,883
|
|
|
1,883
|
|
|
Common stock issued under stock incentive plan and ESPP (in shares) |
|
730,496,000
|
|
|
|
|
Common stock issued under stock incentive plan and ESPP |
1,619
|
$ 1
|
1,618
|
|
|
|
Stock-based compensation expense |
11,359
|
|
11,359
|
|
|
|
Net loss |
(89,289)
|
|
|
|
(89,289)
|
|
Ending balance (in shares) at Mar. 31, 2025 |
|
74,103,192,000
|
|
|
|
|
Ending balance at Mar. 31, 2025 |
$ 1,466,528
|
$ 74
|
2,506,788
|
365
|
(238,213)
|
$ (802,486)
|
Treasury stock, ending balance (in shares) at Mar. 31, 2025 |
|
|
|
|
|
(16,216,411)
|
Beginning balance (in shares) at Dec. 31, 2024 |
57,156,285
|
73,372,696,000
|
|
|
|
|
Beginning balance at Dec. 31, 2024 |
$ 1,540,956
|
$ 73
|
2,493,811
|
(1,518)
|
(148,924)
|
$ (802,486)
|
Treasury stock, beginning balance (in shares) at Dec. 31, 2024 |
(16,216,411)
|
|
|
|
|
(16,216,411)
|
Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
Common stock issued under stock incentive plan and ESPP (in shares) |
3,783
|
|
|
|
|
|
Net loss |
$ (201,309)
|
|
|
|
|
|
Ending balance (in shares) at Jun. 30, 2025 |
58,038,545
|
74,254,956,000
|
|
|
|
|
Ending balance at Jun. 30, 2025 |
$ 1,369,555
|
$ 74
|
2,521,545
|
655
|
(350,233)
|
$ (802,486)
|
Treasury stock, ending balance (in shares) at Jun. 30, 2025 |
(16,216,411)
|
|
|
|
|
(16,216,411)
|
Beginning balance (in shares) at Mar. 31, 2025 |
|
74,103,192,000
|
|
|
|
|
Beginning balance at Mar. 31, 2025 |
$ 1,466,528
|
$ 74
|
2,506,788
|
365
|
(238,213)
|
$ (802,486)
|
Treasury stock, beginning balance (in shares) at Mar. 31, 2025 |
|
|
|
|
|
(16,216,411)
|
Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
Unrealized gain (loss) on available-for-sale securities |
290
|
|
|
290
|
|
|
Common stock issued under stock incentive plan and ESPP (in shares) |
|
151,764,000
|
|
|
|
|
Common stock issued under stock incentive plan and ESPP |
65
|
|
65
|
|
|
|
Stock-based compensation expense |
14,692
|
|
14,692
|
|
|
|
Net loss |
$ (112,020)
|
|
|
|
(112,020)
|
|
Ending balance (in shares) at Jun. 30, 2025 |
58,038,545
|
74,254,956,000
|
|
|
|
|
Ending balance at Jun. 30, 2025 |
$ 1,369,555
|
$ 74
|
$ 2,521,545
|
$ 655
|
$ (350,233)
|
$ (802,486)
|
Treasury stock, ending balance (in shares) at Jun. 30, 2025 |
(16,216,411)
|
|
|
|
|
(16,216,411)
|